• ERT, Bioclinica Rebrand As Clario

    Clinical Research News | ERT today announced that following its early Q2 merger with Bioclinica, the combined company is renamed Clario.

    Nov 3, 2021

  • Follow the Money: Decentralized Trials, Security, COVID Research

    Clinical Research News | Medable’s big Series D, cryptographic data privacy, lung research, collaborative research and more.

    Nov 2, 2021

  • Science 37 Announces Two Partnerships in Japan, Veeva Launches Digital Trials Platform, More

    Clinical Research News | THREAD expands to Europe, Middle East and Africa, TD2 adopts Medidata’s Rave CTMS, Genesis Research enhances its healthcare literature research platform, and RealTime Software improves digital signatures. Plus new products from Trialbee, Vivacare, AliveCor, and more.

    Oct 29, 2021

  • Bringing The Fight To Antimicrobial Resistance: What COVID-19 Has Taught Us About How To Face A Growing Emergency

    Clinical Research News | Even as we make large strides toward the end of the pandemic, there is another growing global health crisis: antimicrobial resistance (AMR). The World Health Organization (WHO) calls AMR one of the top ten public health threats. There is an urgent need to focus on combating the health threat of AMR. The COVID-19 crisis, and the ensuing race to find treatments, has offered innovative and insightful approaches to implementing successful clinical trials related to infectious disease.

    Oct 27, 2021

  • Data-Sharing Platform Aims To Speed Drug Development For Rare Diseases

    Clinical Research News | The Critical Path Institute (C-Path) recently debuted a first-of-its-kind Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) to encourage data-sharing and collaboration among investigators to accelerate treatment innovation for rare diseases. The ultimate value of the platform will be in getting drugs approved quicker.

    Oct 25, 2021

  • Adverse Event Reporting May Need A Total Redo

    Clinical Research News | The reporting of adverse events (AEs) in randomized controlled trials (RCTs) has only modestly improved over the past two decades. But more consistent inclusion of AEs in published studies will not, by itself, provide a balanced picture of the potential harms of interventions.

    Oct 20, 2021

  • Global Consensus Building On Core Outcome Set For ‘Long COVID’ Studies

    Clinical Research News | By the end of this year, consensus by a global coalition of researchers, healthcare providers, and patients on a core set of outcomes that should be included in all future studies of post-COVID syndrome—so-called “long COVID”—are expected to be publicly released. A core outcome set (COS) is urgently needed to optimize and standardize clinical data collection and reporting across clinical trials for the condition.

    Oct 19, 2021